Connect your AI

Core Laboratories CLB Stock-Based Comp

Stock-Based Comp at other companies

Schlumberger SLB

$78M+1.3%

NCS Multistage HoldingsNCSM

$1.23M-15.1%

Baker HughesBKR

$57M+9.6%

Forum Energy TechnologiesFET

$2.52M+38.6%

RPCRES

$3.5M+25.9%

Flowco Holdings Inc.FLOC

$3.09M-37.8%

Other financials

Income statement

Revenue$121.8M-1.4%

Operating income$1.9M-57.3%

Net income-$789.0K-412%

EPS (diluted)-$0.02—

Balance sheet

Cash & equivalents$22.8M+3.2%

Total debt$167.8M-6.8%

Total equity$268.9M+6.1%

Total assets$587.7M+0.3%

Cash flow

Operating cash flow$4.0M-40.5%

CapEx$3.4M+23.8%

Free cash flow$517.0K-86.7%

Valuation

Market cap$492.77M-9.3%

Enterprise value$637.8M-7.6%

P/E17×-1.4×

P/S0.9×-0.1×

Profitability

Operating margin10.3%-0.2pp

Net margin5.5%+0.1pp

FCF margin4.3%-4.6pp

Returns & leverage

Return on equity11.1%-0.4pp

Debt / equity0.6×-0.1×

Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Core Laboratories's stock-based comp?: Core Laboratories (CLB) reported stock-based comp of $5.03M in Q1 2026.
How has Core Laboratories's stock-based comp changed year-over-year?: Core Laboratories's stock-based comp increased by 21.0% year-over-year, from $4.16M to $5.03M.
What is the long-term trend for Core Laboratories's stock-based comp?: Over 2 years (2021 to 2025), Core Laboratories's stock-based comp has grown at a -38.9% compound annual growth rate (CAGR), from $19.09M to $7.14M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.